Last updated: March 27, 2025
Sponsor: University of Utah
Overall Status: Completed
Phase
N/A
Condition
Blood Clots
Treatment
Novel ROTEM interpretation software
Clinical Study ID
NCT05591014
00159279
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Current residents and attending physicians in the University of Utah Department ofAnesthesiology who have a range of experience and exposure to thromboelastography
Exclusion
Exclusion Criteria:
- Refusal to consent or no longer an active member of the University of UtahDepartment of Anesthesiology
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Novel ROTEM interpretation software
Phase:
Study Start date:
April 13, 2023
Estimated Completion Date:
December 31, 2024
Connect with a study center
University of Utah
Salt Lake City, Utah 84132
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.